Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biodesix (BDSX) Accumulated Depreciation & Amortization (2019 - 2026)

Biodesix filings provide 8 years of Accumulated Depreciation & Amortization readings, the most recent being $13.4 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 33.16% to $13.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.4 million, a 33.16% increase, with the full-year FY2025 number at $12.5 million, up 37.03% from a year prior.
  • Accumulated Depreciation & Amortization hit $13.4 million in Q1 2026 for Biodesix, up from $12.5 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $13.4 million in Q1 2026 to a low of $5.6 million in Q4 2023.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $7.6 million (2023), compared with a mean of $8.6 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: decreased 20.03% in 2023 and later soared 62.76% in 2024.
  • Biodesix's Accumulated Depreciation & Amortization stood at $7.0 million in 2022, then fell by 20.03% to $5.6 million in 2023, then soared by 62.76% to $9.1 million in 2024, then surged by 37.03% to $12.5 million in 2025, then increased by 7.13% to $13.4 million in 2026.
  • The last three reported values for Accumulated Depreciation & Amortization were $13.4 million (Q1 2026), $12.5 million (Q4 2025), and $11.7 million (Q3 2025) per Business Quant data.